The Research and Biotechnology Group and Cancer Institute of St. Luke’s Medical Center – Quezon City launched the country’s first Human Cancer Biobank. First in the country, Its primary aim is to collect tumor specimens from patients with cancer, preserve and store these for study by St. Luke’s scientists and cancer experts and analyze the cells on a genetic and molecular level to discover their fundamental components. This groundbreaking facility charts a viable path towards the future of cancer care.
Imagine a world wherein patients receive treatments that tailor fit an individual based on their body and particular disease. Correspondingly, these patients can therefore be tested to determine if they are prone to developing seriousness illnesses in the future and ultimately prevent this from happening by altering their genetic make-up.
“This is the Human Cancer Biobank Project, that we have conceptualized last year, as we saw the need for more precise treatment options for patients”, exclaimed St. Luke’s Medical Center President and CEO Dr. Edgardo R. Cortez during an interview.
Through collaboration with other experts in the country and throughout the world, the St. Luke’s Human Cancer Biobank is the breakthrough project that will pave the way for invention and discovery of innovative methods of diagnosis and treatment of patients for a better tomorrow.